Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 52 Results

Title
Intervention Indication Therapeutic Area Year Actions
Apabetalone in addition to high-intensity statin therapy for preventing major adverse cardiac events in high-risk cardiovascular disease patients with type 2 diabetes mellitus Apabetalone (RVX-208) Major adverse cardiovascular events (MACE) Cardiovascular System , Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Arimoclomol for Niemann-Pick Disease type C - add-on therapy Arimoclomol (BRX-345) Niemann-Pick Disease Endocrine Nutritional and Metabolic Disorders , Genetic Disorders , Neurology 2017 View  |  Download
ATB200/AT2221 for Late onset Pompe disease in adults and adolescents over 12 years – first line ATB200/AT2221 Pompe disease Endocrine Nutritional and Metabolic Disorders , Genetic Disorders 2020 View  |  Download
Avalglucosidase alfa for late-onset Pompe disease Avalglucosidase alfa (neoGAA; GZ-402666) Pompe disease Endocrine Nutritional and Metabolic Disorders , Genetic Disorders 2019 View  |  Download
Bempedoic acid (monotherapy) and bempedoic acid/ezetimibe (fixed-dose combination) for primary hypercholesterolaemia or mixed dyslipidaemia Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653) Mixed dyslipidaemia , Primary hypercholesterolaemia Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Bempedoic acid (monotherapy) or bempedoic acid in combination with ezetimibe for primary hypercholesterolaemia or mixed dyslipidaemia Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653) Mixed dyslipidaemia , Primary hypercholesterolaemia Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Bempedoic acid for primary hypercholesterolaemia or mixed dyslipidaemia in patients unable to reach cholesterol goals with the maximum tolerated dose of a statin Bempedoic acid (ETC-1002; Nilemdo) Mixed dyslipidaemia , Primary hypercholesterolaemia Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Bis-choline tetrathiomolybdate for Wilson's disease Bis-choline tetrathiomolybdate (Decuprate; ATN-224; WTX101; ALXN1840) Wilson's disease Endocrine Nutritional and Metabolic Disorders , Genetic Disorders 2021 View  |  Download
Brolucizumab for visual impairment due to diabetic macular oedema Brolucizumab (RTH258; ESBA1008; Beovu) Visual impairment Endocrine Nutritional and Metabolic Disorders , Ophthalmology 2020 View  |  Download
Burosumab for x-linked hypophosphataemia in adults Burosumab (Crystiva; KRN23) Hypophosphataemia Endocrine Nutritional and Metabolic Disorders 2020 View  |  Download
1 2 3 5 6
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications